QNTM: Quantum Biopharma Ltd.
About
Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
Current Value
$4.971 Year Return
Current Value
$4.971 Year Return
Key Details
Market Cap
$9.19M
P/E Ratio
-0.33
1Y Stock Return
-94.36%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
0.6
Strategies that include QNTM
Stock's related to QNTM
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DOCS | 50.45% | $9.62B | +114.35% | 0.00% |
| G | 49.48% | $7.83B | +31.86% | 1.34% |
| CARG | 44.91% | $3.68B | +69.13% | 0.00% |
| ADMA | 35.82% | $4.88B | +423.60% | 0.00% |
| TBRG | 34.49% | $244.47M | +52.66% | 0.00% |
| IOVA | 33.19% | $2.50B | +58.41% | 0.00% |
| AKAM | 33.05% | $13.12B | -22.78% | 0.00% |
| SG | 31.37% | $4.38B | +299.68% | 0.00% |
| RCEL | 29.76% | $321.96M | +27.43% | 0.00% |
| XGN | 28.81% | $62.26M | +127.74% | 0.00% |
| EVH | 28.35% | $1.39B | -58.46% | 0.00% |
| ALDX | 27.21% | $294.18M | +102.46% | 0.00% |
| TTD | 26.02% | $58.94B | +81.35% | 0.00% |
| HEAR | 25.83% | $300.79M | +44.04% | 0.00% |
| BLFS | 25.83% | $1.04B | +64.64% | 0.00% |
| HRTG | 25.71% | $371.89M | +58.22% | 0.00% |
| NWSA | 25.11% | $16.38B | +34.27% | 0.69% |
| EHTH | 25.05% | $143.72M | -37.66% | 0.00% |
| DIOD | 24.79% | $2.53B | -20.36% | 0.00% |
| EXPE | 24.33% | $22.72B | +30.70% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BGC | -<0.01% | $4.97B | +59.88% | 0.48% |
| DAR | <0.01% | $6.65B | -3.02% | 0.00% |
| WBD | -0.01% | $23.31B | -10.21% | 0.00% |
| NWL | -0.01% | $3.67B | +20.00% | 3.04% |
| INFU | -0.01% | $193.50M | -1.62% | 0.00% |
| NMM | -0.01% | $1.58B | +126.51% | 0.38% |
| LNN | 0.01% | $1.35B | +3.22% | 1.14% |
| UPS | 0.02% | $113.67B | -11.06% | 4.89% |
| MNR | -0.02% | $1.66B | -10.71% | 15.90% |
| CRSR | 0.02% | $689.97M | -47.32% | 0.00% |
| GIS | -0.03% | $34.85B | -2.91% | 3.78% |
| PBH | -0.03% | $4.07B | +41.93% | 0.00% |
| ATEN | -0.03% | $1.21B | +34.32% | 1.46% |
| TAC | -0.03% | $3.09B | +31.01% | 1.68% |
| DDD | -0.04% | $402.06M | -35.13% | 0.00% |
| ACGL | 0.04% | $36.00B | +16.84% | 0.00% |
| SHG | 0.04% | $19.42B | +36.63% | 2.96% |
| WEN | -0.04% | $3.67B | -4.25% | 5.54% |
| NGNE | -0.04% | $223.88M | +32.95% | 0.00% |
| AMTB | 0.04% | $998.39M | +13.94% | 1.53% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PCRX | -56.66% | $772.48M | -37.25% | 0.00% |
| AVD | -41.77% | $182.80M | -32.45% | 1.42% |
| MITK | -39.98% | $401.51M | -22.13% | 0.00% |
| PUBM | -33.81% | $739.82M | -2.82% | 0.00% |
| FIVN | -29.32% | $2.83B | -49.23% | 0.00% |
| NFE | -22.88% | $2.29B | -74.75% | 3.32% |
| SAVA | -22.79% | $1.35B | +25.50% | 0.00% |
| AQN | -20.53% | $3.79B | -20.96% | 8.21% |
| GSBD | -20.52% | $1.53B | - | 13.99% |
| RWAY | -18.48% | $394.72M | -17.18% | 15.47% |
| NATR | -18.26% | $295.06M | -7.42% | 0.00% |
| UEIC | -16.75% | $148.52M | +43.22% | 0.00% |
| ARLO | -16.58% | $1.20B | +31.21% | 0.00% |
| PODD | -16.11% | $18.38B | +44.49% | 0.00% |
| GRVY | -14.81% | $466.13M | -4.24% | 0.00% |
| MCK | -14.26% | $78.15B | +35.51% | 0.42% |
| FIGS | -14.17% | $840.56M | -25.56% | 0.00% |
| MTUS | -14.15% | $623.82M | -27.79% | 0.00% |
| BTG | -13.89% | $3.67B | -6.35% | 5.72% |
| ASPS | -13.69% | $22.36M | -80.26% | 0.00% |
ETF's related to QNTM
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| CGBL | 17.89% | $1.17B | 0.33% |
| ILF | 16.30% | $1.30B | 0.48% |
| EWZ | 16.18% | $3.72B | 0.59% |
| FLLA | 15.50% | $48.48M | 0.19% |
| EMHY | 14.82% | $448.75M | 0.5% |
| XAR | 14.79% | $2.56B | 0.35% |
| VFLO | 14.66% | $1.35B | 0.39% |
| PTH | 14.45% | $143.31M | 0.6% |
| ITA | 14.27% | $6.36B | 0.4% |
| PPH | 13.97% | $592.06M | 0.36% |
| SYLD | 13.91% | $1.29B | 0.59% |
| JEPI | 13.72% | $36.72B | 0.35% |
| EWZS | 13.65% | $125.67M | 0.59% |
| REZ | 13.56% | $1.18B | 0.48% |
| PPA | 13.48% | $4.62B | 0.57% |
| AGZD | 13.33% | $142.76M | 0.23% |
| COWZ | 13.29% | $26.05B | 0.49% |
| GDIV | 13.29% | $278.69M | 0.5% |
| IZRL | 13.24% | $102.75M | 0.49% |
| XME | 13.22% | $1.86B | 0.35% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| CNBS | 0.02% | $21.10M | 0.77% |
| TDTT | -0.03% | $1.84B | 0.18% |
| PINK | -0.05% | $161.15M | 0.5% |
| TDTF | 0.05% | $719.61M | 0.18% |
| GVI | -0.06% | $3.42B | 0.2% |
| TPMN | -0.07% | $40.60M | 0.65% |
| HYZD | 0.09% | $161.49M | 0.43% |
| TOTL | 0.14% | $3.31B | 0.55% |
| GREK | -0.17% | $180.76M | 0.57% |
| GOVT | -0.19% | $28.65B | 0.05% |
| MUNI | -0.21% | $1.73B | 0.35% |
| BSCR | 0.23% | $2.30B | 0.1% |
| EAGG | -0.25% | $3.68B | 0.1% |
| SPTI | -0.27% | $6.70B | 0.03% |
| JCPB | 0.29% | $4.55B | 0.38% |
| LGOV | -0.31% | $607.48M | 0.67% |
| MSOS | -0.33% | $632.80M | 0.83% |
| IBTJ | 0.35% | $379.57M | 0.07% |
| IBTG | -0.35% | $1.48B | 0.07% |
| VTIP | 0.36% | $11.71B | 0.04% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -22.10% | $195.31M | 0.85% |
| TAIL | -12.09% | $67.98M | 0.59% |
| CSHI | -10.75% | $482.85M | 0.38% |
| JUCY | -7.10% | $324.29M | 0.6% |
| BTAL | -6.48% | $388.04M | 1.43% |
| IVOL | -6.45% | $548.70M | 1.02% |
| PHDG | -6.43% | $113.97M | 0.39% |
| PWZ | -6.20% | $697.36M | 0.28% |
| PREF | -6.10% | $999.92M | 0.55% |
| USDU | -5.94% | $201.97M | 0.5% |
| HDRO | -5.75% | $164.26M | 0.3% |
| DFNM | -5.41% | $1.40B | 0.17% |
| XHLF | -5.36% | $874.27M | 0.03% |
| FMHI | -4.94% | $747.15M | 0.7% |
| FTSM | -4.64% | $6.08B | 0.45% |
| ULST | -4.38% | $535.47M | 0.2% |
| VGSH | -4.35% | $19.14B | 0.04% |
| IBDP | -4.30% | $2.11B | 0.1% |
| FLBL | -4.26% | $645.58M | 0.45% |
| IBD | -4.10% | $330.68M | 0.44% |
News
Yahoo
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, ...
Yahoo
To assist enquiries the copy of the complaint can be viewed by clicking the following link: Quantum Bio Pharma Complaint TORONTO, ON / ACCESSWIRE / October 22, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or ...
Yahoo
Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the Company and its shareholders Toronto, Ontario--(Newsfile Corp. - October 21, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and b
Yahoo
Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the Company and its shareholders ...
Yahoo
Toronto, Ontario--(Newsfile Corp. - October 7, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma") provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu" or the "Company"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting
Yahoo
TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative ...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.